Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0658
D

Failure to Monitor High-Risk Medication and Address Syncopal Episodes

Ripon, California Survey Completed on 09-08-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure safe monitoring practices for a high-risk medication, metoprolol, prescribed to a resident with a history of atrial fibrillation and hypertension. The medication order did not include parameters for when to hold or administer the drug based on the resident’s blood pressure (BP) or heart rate (HR). Multiple instances of abnormal BP and HR readings were documented, but there was no evidence that these results were reviewed with the resident’s physician or that the medication order was clarified to include necessary monitoring parameters. The consultant pharmacist also confirmed that recommendations for daily monitoring should have been made, but he was not notified of the resident’s syncopal episodes or abnormal vital signs during his reviews. The resident experienced multiple syncopal episodes, particularly during transfers using a standing lift, which were not consistently reported by the certified nursing assistant (CNA) to the licensed nurse (LN). When episodes were documented, there was no evidence that the resident was assessed for orthostatic hypotension or that orthostatic BP and HR checks were performed. Several LNs acknowledged during interviews that further assessment and monitoring should have occurred, and that the physician should have been notified to provide more accurate medication parameters. However, these actions were not taken, and the episodes were not communicated to the consultant pharmacist or the physician in a timely manner. The Director of Nursing (DON) was unaware of the frequency of the resident’s syncopal episodes and only became aware of one such event. Upon review, the DON acknowledged that the resident’s fluctuating BP and HR, combined with a history of syncope, warranted holding the medication, performing orthostatic checks, and notifying the physician. The facility’s policy required physician notification and inclusion of parameters for abnormal BP and HR, but these procedures were not followed, resulting in a failure to ensure safe medication administration and monitoring for the resident.

An unhandled error has occurred. Reload 🗙